Global Metabolic Disorders Therapeutics Market is Envisaged to Result in its Impressive CAGR of More than 4.62% by 2020

Global Metabolic Disorders Therapeutics Market 2016-2020 Size and Share Published in 2016-09-27 Available for US$ 2500 at Researchmoz.us

Description

About Metabolic Disorders

Metabolic disorders occur as a result of disruption of chemical processes and conversions occurring in the cells and fluids of the body. This is mainly because of defects in the enzyme; all process in the body are controlled by enzymes. Any disruption in the pathways involved in the development and metabolism of carbohydrates, proteins, fats, and nucleic acids, results in the development of metabolic disorders.

Technavios analysts forecast the global metabolic disorders therapeutics market to grow at a CAGR of 4.62% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global metabolic disorders therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of various metabolic disorders including diabetes, obesity, lysosomal storage diseases, and hypercholesterolemia.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio’s report, Global Metabolic Disorders Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Novo Nordisk

Sanofi

Merck

AstraZeneca

Eli Lilly

Get a Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=834741

Other prominent vendors

AbbVie

Actelion Pharmaceuticals

Adocia

Aegerion Pharmaceuticals

Akros Pharma

Alnylam Pharmaceuticals

Amarin

nAmgen

Amicus Therapeutics

Arbutus Biopharma

Arena Pharmaceuticals

Astellas Pharma

Atheronova

Aurobindo Pharma

Baxalta

Belrose Pharma

BHV Pharma

Biocon

Biodel

BioMarin

Bionaturis

Biosidus

Biospherics

Boehringer Ingelheim

Bristol-Myers Squibb

Catabasis Pharmaceuticals

Cerenis Therapeutics

Chipscreen Biosciences

Cipla

CJ HealthCare

CKD Bio

Concord Biotech

ConjuChem

CureDm

CymaBay Therapeutics

Daewoong

Daiichi Sankyo

Dance Biopharm

DiaMedica

Diamyd Therapeutics

Diasome Pharmaceuticals

DiaVacs

Dong-A ST

Eisai

Elcelyx Therapeutics

Esperion Therapeutics

Exsulin

F. Hoffmann-La Roche

Gan & Lee Pharmaceuticals

Generex Biotechnology

Genfit

GlaxoSmithKline

HanAll BioPharma

Hanmi Pharmaceutical Company

Hua Medicine

Iltoo Pharma

Intarcia Therapeutics

InteKrin Therapeutics

Intrexon

Ionis Pharmaceuticals

Islet Sciences

ISU Abxis

Janssen Pharmaceuticals

Japan Tobacco

JCR Pharmaceuticals

JW Pharmaceuticals

Kadmon Pharmaceuticals

Kamada

KinDex Pharmaceuticals

Kissei

Kotobuki

Kowa Company

Laboratoires SMB

Lexicon Pharmaceuticals

Ligand Pharmaceuticals

Living Cell Technologies

Livzon

LIXTE Biotechnology

Lupin

MacroGenics

Madrigal Pharmaceuticals

MannKind

MedImmune

Melior Pharmaceuticals

Merrion Pharmaceuticals

Merz Pharmaceuticals

Metabolic Solutions Development Company

Mitsubishi Tanabe Pharma

Mylan

Neothetics

Neuraltus Pharmaceuticals

NGM Biopharmaceuticals

NGM Biopharmaceuticals

Norgine BV

Novartis

NuSirt Biopharma

Oramed

Orexigen Therapeutics

Osiris Therapeutics

Peptron

Perle Biosciences

Pfizer

PhaseBio Pharmaceuticals

Poxel

Protalix Biotherapeutics

Raptor

Recordati

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

REGiMMUNE

Rhythm Pharmaceuticals

Saniona

Santaris Pharma

Santaris Pharma

Serometrix

Shionogi

Shire

Sigma-Tau

Sirona Biochem

Strongbridge Biopharma

SUN Pharma

Takeda

Teva

Thera technologies

Theracos

Toleranzia

Tolerion

Torrent Pharmaceuticals

Transition Therapeutics

UCB

Utrecht Holdings

VeroScience

Vivus

vTv Therapeutics

XBiotech

Xeris Pharmaceuticals

XOMA

Zafgen

Zydus Cadila

Market driver

Increase in academia-industry collaborations for drug development

For a full, detailed list, view our report

Market challenge

Low compliance and adherence rates

For a full, detailed list, view our report

Market trend

Increase in academia-industry collaborations for drug development

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=834741

Table of Content

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Pipeline portfolio

Pipeline portfolio: Global diabetes drugs market

Pipeline portfolio: Global hyperphosphatemia drugs market

Pipeline portfolio: Global anti-obesity drugs market

PART 06: Market landscape

Market overview

Market size and forecast

Five forces analysis

Browse All Cardiovascular Devices Market Research Reports at: http://www.researchmoz.us/cardiovascular-devices-market-reports-61.html

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/